Literature DB >> 28089179

Type 2 Diabetes, Obesity, and Aspirin Responsiveness.

Carlo Patrono1, Bianca Rocca2.   

Abstract

Entities:  

Keywords:  antiplatelet drugs; cyclooxygenase-1; pharmacodynamics; pharmacokinetics; platelets; thromboxane B(2)

Mesh：

Substances：

Year:  2017        PMID： 28089179     DOI： 10.1016/j.jacc.2016.11.049

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  10 in total

1.  Aspirin and diabetes mellitus in primary prevention: the Endless Conundrum.

Authors:  Rubén Casado-Arroyo
Journal:  Ann Transl Med       Date:  2018-06

2.  Performance Evaluation of Parametric and Nonparametric Methods When Assessing Effect Measure Modification.

Authors:  Gabriel Conzuelo Rodriguez; Lisa M Bodnar; Maria M Brooks; Abdus Wahed; Edward H Kennedy; Enrique Schisterman; Ashley I Naimi
Journal:  Am J Epidemiol       Date:  2022-01-01       Impact factor: 5.363

Review 3.  The dilemma of aspirin resistance in obese patients.

Authors:  Devarshi Ardeshna; Sarthak Khare; Pooja S Jagadish; Venugopal Bhattad; Brandon Cave; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2019-09

4.  Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome.

Authors:  William A E Parker; Rachel C Orme; Jessica Hanson; Hannah M Stokes; Claire M Bridge; Patricia A Shaw; Wael Sumaya; Kirstie Thorneycroft; Giovanna Petrucci; Benedetta Porro; Heather M Judge; Ramzi A Ajjan; Bianca Rocca; Robert F Storey
Journal:  Platelets       Date:  2019-02-13       Impact factor: 3.862

5.  Association of Aspirin Use With Mortality Risk Among Older Adult Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Authors:  Holli A Loomans-Kropp; Paul Pinsky; Yin Cao; Andrew T Chan; Asad Umar
Journal:  JAMA Netw Open       Date:  2019-12-02

Review 6.  Measurement of Thromboxane Biosynthesis in Health and Disease.

Authors:  Carlo Patrono; Bianca Rocca
Journal:  Front Pharmacol       Date:  2019-10-30       Impact factor: 5.810

Review 7.  MicroRNA as Potential Biomarkers of Platelet Function on Antiplatelet Therapy: A Review.

Authors:  Pamela Czajka; Alex Fitas; Daniel Jakubik; Ceren Eyileten; Aleksandra Gasecka; Zofia Wicik; Jolanta M Siller-Matula; Krzysztof J Filipiak; Marek Postula
Journal:  Front Physiol       Date:  2021-04-15       Impact factor: 4.566

8.  Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing.

Authors:  Alberto Giaretta; Giovanna Petrucci; Bianca Rocca; Gianna Maria Toffolo
Journal:  PLoS One       Date:  2022-08-17       Impact factor: 3.752

9.  Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.

Authors:  Peter M Rothwell; Nancy R Cook; J Michael Gaziano; Jacqueline F Price; Jill F F Belch; Maria Carla Roncaglioni; Takeshi Morimoto; Ziyah Mehta
Journal:  Lancet       Date:  2018-07-17       Impact factor: 79.321

Review 10.  The role of aspirin in the prevention of ovarian, endometrial and cervical cancers.

Authors:  Nalinie Joharatnam-Hogan; Fay H Cafferty; Archie Macnair; Alistair Ring; Ruth E Langley
Journal:  Womens Health (Lond)       Date:  2020 Jan-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.